Camden National Corporation
NASDAQ:CACBanks - Regional
+$0.02 today
- Market cap
- $981.28M
- Beta
- 0.56
- P/E (TTM)
- 10.9
- EPS (TTM)
- $4.70
- Dividend yield
- 3.27%
Volume 0.06M
Average 0.10M
CAC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Camden National CorporationNASDAQ: CAC
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $1.78M (cash outflow) rose 0.9% year over year, ahead of the -15.7% change in trailing-twelve-month capital expenditures. Sequentially, it rose 0.2% from the prior quarter. Over 3 fiscal years it compounded at +37.8% a year.
Context
- Capital expenditures amounted to 1.6% of revenue in FY2025, down 0.4 pp from a year earlier.
- Capital expenditures grew in size in 3 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +0.9% holds above the trailing-twelve-month pace of -15.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (5.71M) USD
- Year-over-year change
- -2.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (5.71M) | -2.4% |
| FY2024 | 2024-12-31 | (5.58M) | -112.7% |
| FY2023 | 2023-12-31 | (2.62M) | -20.1% |
| FY2022 | 2022-12-31 | (2.18M) | -17.9% |
| FY2021 | 2021-12-31 | (1.85M) | — |
Capital Expenditures vs competitors
How CAC compares with its peers on the latest reported figures
- CAC's LTM Mar 2026 capital expenditures of $5.72M is the 2nd largest of the 11 companies compared; the peer median is $1.91M.
- Its year-over-year change of -15.7% is the 5th highest of 11, against a peer median of -43.0%.
- Capital expenditures amounts to 1.6% of revenue for CAC, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $6.49M | -26.6% | +6.3% | 2.4% | |
| LTM Mar 2026 | $5.72M | -15.7% | +37.8% | 1.6% | |
| LTM Mar 2026 | $4.97M | -68.1% | -19.8% | 1.1% | |
| LTM Mar 2026 | $4.19M | +20.3% | +52.4% | 3.6% | |
| LTM Mar 2026 | $2.67M | +56.6% | -16.6% | 1.6% | |
| LTM Mar 2026 | $2.13M | +38.2% | -15.9% | 1.1% | |
| LTM Mar 2026 | $1.7M | -257.0% | -15.9% | 0.8% | |
| LTM Mar 2026 | $1.22M | -59.3% | +2.8% | 1.0% | |
| LTM Mar 2026 | $1.22M | -64.8% | -31.1% | 0.3% | |
| LTM Mar 2026 | $312K | -67.5% | +2.2% | 0.4% | |
| LTM Mar 2026 | $302K | +107.7% | +29.6% | 0.4% | |
| Peer median (excluding CAC) | $1.91M | -43.0% | -6.9% | 1.0% | |
Competitors are the stored peer set for CAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 69.01M | 61.44M | 43.38M | 53M | 65.16M |
| Depreciation & Amortization | 4.36M | 4.12M | 3.96M | 3.87M | 11.1M |
| Deferred Income Tax | (637K) | 1.79M | 1.31M | 298K | 616K |
| Stock-Based Compensation | 2.38M | 2.55M | 2.79M | 2.9M | 3.42M |
| Change in Working Capital | 3.29M | (4.69M) | 6.38M | 349K | (15.78M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 3.29M | (4.69M) | 6.38M | 349K | (15.78M) |
| Other Non-Cash Items | 64.31M | 39.98M | 9.68M | 514K | (604K) |
| Operating Cash Flow | 142.72M | 105.18M | 67.51M | 60.93M | 63.91M |
| Capital Expenditures | (1.85M) | (2.18M) | (2.62M) | (5.58M) | (5.71M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 48.26M |
| Purchases of Investments | (758.85M) | (138.17M) | (137.13M) | (60.39M) | (240.46M) |
| Sales of Investments | 321.63M | 233.67M | 225.13M | 123.06M | 209.09M |
| Other Investing Activities | (210.02M) | (581.04M) | (92.41M) | (26.76M) | (67.6M) |
| Investing Cash Flow | (649.09M) | (487.72M) | (7.03M) | 30.33M | (56.41M) |
| Debt Repayment | 9.02M | 53.41M | 220.26M | 14.73M | (28.68M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | (537K) |
| Common Stock Repurchased | (10.09M) | (10.24M) | (2M) | (1.61M) | 0 |
| Dividends Paid | (21.08M) | (23.51M) | (24.54M) | (24.56M) | (28.47M) |
| Other Financing Activities | 603.38M | 217.69M | (229.83M) | 35.34M | (67.29M) |
| Financing Cash Flow | 581.23M | 237.34M | (36.1M) | 23.9M | (124.97M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 74.85M | (145.2M) | 24.38M | 115.16M | (117.47M) |
| Free Cash Flow | 140.86M | 103M | 64.89M | 55.36M | 58.2M |
Camden National Corporation
NASDAQ:CAC
Intrinsic Alpha fair value
Locked
Current Price
$58.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.